Skip to content

The progression and clinical outcome of atherosclerotic plaque determined by coronary computed tomography angiography imaging: a comprehensive exploration from a retrospective single-center serial study

The progression and clinical outcome of atherosclerotic plaque determined by coronary computed tomography angiography imaging: a comprehensive exploration from a retrospective single-center serial study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079021
Enrollment
Unknown
Registered
2023-12-22
Start date
2023-10-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atheriosclerotic cardiovascular disease

Interventions

Grouping based on different outcomes:None

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age > 18 years old; 2. CCTA image quality meets basic analysis requirements; 3. Clinical data is complete and valid within 1 month before or after CCTA examination; 4. No serious liver or kidney diseases or other malignant diseases that seriously affect long-term prognosis.

Exclusion criteria

Exclusion criteria: 1. CCTA image exists severe noise or artifacts; 2. Abnormal origin, course, or termination of coronary arteries; 3. CCTA examination for non ASCVD reasons.

Design outcomes

Secondary

MeasureTime frame
coronary artery calcium score;epicardial adipose tissue volume;coronary artery anatomical score;major adverse cardiovascular events;

Primary

MeasureTime frame
CCTA routine assessment;CCTA plaque quantitative analysis;CT-fractional flow reserve;fat attenuation index;

Countries

China

Contacts

Public ContactYundai Chen

Senior Department of Cardiology, Chinese PLA General Hospital

cyundai@vip.163.com+86 133 1111 9778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026